Literature DB >> 21684708

Exploring the short-term impact of DNA-testing in breast cancer patients: the counselees' perception matters, but the actual BRCA1/2 result does not.

Joël Vos1, Jan C Oosterwijk, Encarna Gomez-Garcia, Fred H Menko, Margriet J Collee, Christi J van Asperen, Anna M Jansen, Anne M Stiggelbout, Aad Tibben.   

Abstract

OBJECTIVE: Previous studies suggest that learning a DNA-test-result has no direct impact on the medical-decisions and psychological well-being of counselees. Their perception, especially their recollections and interpretations of their cancer-risks and heredity, predict and/or mediate this impact. These studies were criticized for their small range of predictors, mediators, outcomes and contextual factors. We studied the short-term impact of DNA-testing with an extended model.
METHODS: Three months after disclosure of BRCA1/2-test-results, we sent counselees a questionnaire about their perception, medical and psychological outcomes, and medical, familial and psychological contexts. 248 affected women participated; 30 had received pathogenic-mutations, 16 unclassified-variants and 202 uninformative-results.
RESULTS: The actually communicated genetic-information and the contextual variables predicted the counselees' perception, but did not directly predict any outcomes. The counselees' perception predicted and/or completely mediated the counselees' medical intentions and behavior, physical and psychological life-changes, stigma, mastery, negativity and cancer-worries. Short-term distress was related to the perception not only of their own risks, but also of their relatives' risks and heredity-likelihood. Effect sizes were medium to large. CONCLUSIONS AND IMPLICATIONS: The outcomes of DNA-testing were better predicted by the counselees' perception than by the actually given genetic-information. We recommend genetic-counselors to have tailored, interactive dialogues about the counselees' perception.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21684708     DOI: 10.1016/j.pec.2011.04.017

Source DB:  PubMed          Journal:  Patient Educ Couns        ISSN: 0738-3991


  14 in total

Review 1.  The Life Course Perspective: a Guide for Genetic Counselors.

Authors:  Rebekah J Hamilton; Nancy A Innella; Dawn T Bounds
Journal:  J Genet Couns       Date:  2015-08-27       Impact factor: 2.537

2.  Experiences and interpretations of BRCA1/2 testing among women affected by breast or ovarian cancer who received a negative result.

Authors:  Lesley Stafford; Alison Flehr; Fiona Judd; Geoffrey J Lindeman; Penny Gibson; Angela Komiti; G Bruce Mann; Maira Kentwell
Journal:  J Community Genet       Date:  2019-03-27

3.  Perceived risk for cancer progression and psychological status in chronic lymphocytic leukemia patients: CALGB 70603 (Alliance).

Authors:  Teresa L Deshields; Amylou C Dueck; Kerry Rogers; Jennifer R Brown; Tait Shanafelt; David Mintzer; John C Byrd
Journal:  Leuk Lymphoma       Date:  2019-03-27

Review 4.  100 years Lynch syndrome: what have we learned about psychosocial issues?

Authors:  Eveline M A Bleiker; Mary Jane Esplen; Bettina Meiser; Helle Vendel Petersen; Andrea Farkas Patenaude
Journal:  Fam Cancer       Date:  2013-06       Impact factor: 2.375

5.  Comparison of the screening practices of unaffected noncarriers under 40 and between 40 and 49 in BRCA1/2 families.

Authors:  Christelle Duprez; Véronique Christophe; Isabelle Milhabet; Aurélie Krzeminski; Claude Adenis; Pascaline Berthet; Jean-Philippe Peyrat; Philippe Vennin
Journal:  J Genet Couns       Date:  2013-01-25       Impact factor: 2.537

6.  Patient compliance based on genetic medicine: a literature review.

Authors:  Kai Insa Schneider; Jörg Schmidtke
Journal:  J Community Genet       Date:  2013-08-10

7.  Development and Evaluation of a Telephone Communication Protocol for the Delivery of Personalized Melanoma Genomic Risk to the General Population.

Authors:  Georgina L Fenton; Amelia K Smit; Lucinda Freeman; Caro Badcock; Kate Dunlop; Phyllis N Butow; Judy Kirk; Anne E Cust
Journal:  J Genet Couns       Date:  2017-12-03       Impact factor: 2.537

8.  Cancer Health Assessments Reaching Many (CHARM): A clinical trial assessing a multimodal cancer genetics services delivery program and its impact on diverse populations.

Authors:  Kathleen F Mittendorf; Tia L Kauffman; Laura M Amendola; Katherine P Anderson; Barbara B Biesecker; Michael O Dorschner; Devan M Duenas; Donna J Eubanks; Heather Spencer Feigelson; Marian J Gilmore; Jessica Ezzell Hunter; Galen Joseph; Stephanie A Kraft; Sandra Soo Jin Lee; Michael C Leo; Elizabeth G Liles; Nangel M Lindberg; Kristin R Muessig; Sonia Okuyama; Kathryn M Porter; Leslie S Riddle; Bradley A Rolf; Alan F Rope; Jamilyn M Zepp; Gail P Jarvik; Benjamin S Wilfond; Katrina A B Goddard
Journal:  Contemp Clin Trials       Date:  2021-05-11       Impact factor: 2.261

9.  Short-term psychological impact of the BRCA1/2 test result in women with breast cancer according to their perceived probability of genetic predisposition to cancer.

Authors:  A Brédart; J L Kop; A Depauw; O Caron; S Sultan; D Leblond; A Fajac; B Buecher; M Gauthier-Villars; C Noguès; C Flahault; D Stoppa-Lyonnet; S Dolbeault
Journal:  Br J Cancer       Date:  2013-03-05       Impact factor: 7.640

10.  Counselees' Expressed Level of Understanding of the Risk Estimate and Surveillance Recommendation are Not Associated with Breast Cancer Surveillance Adherence.

Authors:  Akke Albada; Sandra van Dulmen; Henrietta Dijkstra; Ivette Wieffer; Arjen Witkamp; Margreet G E M Ausems
Journal:  J Genet Couns       Date:  2015-09-01       Impact factor: 2.537

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.